{
    "code": "02004405",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02004405",
    "time": "2016-04-22 03:19:44",
    "許可證字號": "衛署藥輸字第004405號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/07\/13",
    "發證日期": "65\/07\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200440500",
    "中文品名": "能克淚明",
    "英文品名": "LACRIMIN OPHTHALMIC SOLUTION",
    "適應症": "分泌性流淚症",
    "劑型": "472點眼液劑",
    "包裝": "100公撮以下瓶裝 單支及拾支盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "OXYBUPROCAINE HYDROCHLORIDE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1433601100  台灣參天製藥股份有限公司",
    "申請商地址": "台北市中山區松江路126號9樓之1",
    "主製造廠": {
        "製造廠名稱": "F260270200  SANTEN PHARMACEUTICAL CO., LTD. SHIGA PLANT",
        "製造廠廠址": "348-3, AZA-SUWA, OAZA-SHIDE, TAGACHO INUKAMIGUN, SHIGA, JAPAN",
        "製造廠公司地址": "",
        "製造廠國別": "JAPAN",
        "製程": "成品製造廠"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F260270000  SANTEN PHARMACEUTICAL CO. LTD.(NOTO PLANT)",
            "製造廠廠址": "2-14, SHIKINAMI,HODATSUSHIMIZU-CHO, HAKUI-GUN, ISHIKAWA, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "包裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5216000120",
            "成分名稱": "OXYBUPROCAINE HYDROCHLORIDE",
            "含量描述": "",
            "含量": "0.0500000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "02-004405 Lacrimin_Package insert_150312-104-04-16.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004405&Seq=005&Type=9"
        },
        {
            "title": "TW Lacrimin PI (07)-102-11-13.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004405&Seq=004&Type=9"
        },
        {
            "title": "020044050003.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004405&Seq=003&Type=9"
        },
        {
            "title": "020044050002.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004405&Seq=002&Type=9"
        },
        {
            "title": "020044050001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004405&Seq=001&Type=9"
        },
        {
            "title": "02-004405 Lacrimin_TW_bottle Label_150316-104-04-16.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004405&Seq=007&Type=8"
        },
        {
            "title": "02-004405 Lacrimin_TW_5mL X 10 box_08-104-04-16.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004405&Seq=006&Type=8"
        },
        {
            "title": "02-004405 Lacrimin_TW_5mL X 1 box_141218-104-04-16.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004405&Seq=005&Type=8"
        },
        {
            "title": "020044050004.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004405&Seq=004&Type=8"
        },
        {
            "title": "020044050003.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004405&Seq=003&Type=8"
        },
        {
            "title": "020044050002.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004405&Seq=002&Type=8"
        },
        {
            "title": "020044050001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02004405&Seq=001&Type=8"
        }
    ]
}